Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 15, 2025 • 10:00 PM ET

Date/Time Source News Release
05/30/2025 08:00 AM EDT Canada Newswire BIOVAXYS ANNOUNCES CONSOLIDATION AND CONCURRENT BROKERED PRIVATE PLACEMENT OFFERING FOR GROSS PROCEEDS OF UP TO $3,000,000
03/03/2025 06:19 PM EST Canada Newswire BioVaxys Technology Corp. Granted Management Cease Trade Order
02/18/2025 06:27 PM EST Canada Newswire BioVaxys Announces Debt Settlement Agreement, Extension of Private Placement Closing Date and Closing of The Fourth and Final Tranche of Private Placement
01/23/2025 08:01 PM EST Canada Newswire BIOVAXYS ANNOUNCES EXTENSION OF PRIVATE PLACEMENT CLOSING DATE
01/16/2025 07:31 AM EST PR Newswire BioVaxys Developing DPX to be the Carrier of Choice for mRNA Vaccines, a market projected to grow to USD$48,000,000,000 by 2030*
01/10/2025 08:28 PM EST Canada Newswire BIOVAXYS ANNOUNCES CLOSING OF THIRD TRANCHE OF PRIVATE PLACEMENT
12/13/2024 06:27 PM EST Canada Newswire BIOVAXYS ANNOUNCES CLOSING OF FIRST TRANCHE OF PRIVATE PLACEMENT AND ANNOUNCES DEBT SETTLEMENT AGREEMENT
12/11/2024 01:00 AM EST Canada Newswire BIOVAXYS ANNOUNCES REPRICING OF PRIVATE PLACEMENT OFFERING
12/05/2024 07:00 AM EST Canada Newswire BioVaxys Shares New Data on its DPX(TM) Immune Educating Platform at Personalized Cancer Vaccine Summit
11/05/2024 05:00 AM EST Canada Newswire BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium
Page

Additional News

As of June 15, 2025 • 10:00 PM ET

Date/Time Source News Release
06/03/2025 06:56 PM EDT Markets and Headlines BioVaxys Issues Corporate Update
05/29/2025 08:42 PM EDT Markets and Headlines BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA")
05/07/2025 10:06 AM EDT Baystreet New Approaches to Tumor Targeting Are Driving the Next Wave of Oncology Breakthroughs
05/07/2025 08:01 AM EDT Markets and Headlines BioVaxys and Sona Nanotech Enter Research Collaboration
04/23/2025 10:04 AM EDT Baystreet Zoonotic Threats, Invasive Species, and Food Chain Shocks: Why Animal Biotech Is on Watchlists Now
04/22/2025 03:15 PM EDT InvestorBrandNetwork InvestorNewsBreaks - BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (FRA: 5LB), SpayVac-for-Wildlife Inc. Expand License Agreement
04/22/2025 08:34 AM EDT Markets and Headlines BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture
02/28/2025 09:10 AM EST InvestorIdeas.com New Biotech Stocks at Investorideas.com
01/16/2025 09:20 AM EST Baystreet How Advanced Drug Delivery is Revolutionizing Global Healthcare in 2025
12/18/2024 09:35 AM EST Baystreet New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.